4Filed Aug 17, 8:00 PM ET

Bruker (BRKR) CFO Herman Gerald Receives RSU & Option Grants

$BRKR · BRUKER CORP

Research Summary

AI-generated summary of this SEC filing

Updated

Bruker (BRKR) CFO Herman Gerald Receives RSU & Option Grants

What Happened Herman Gerald N, Executive Vice President and Chief Financial Officer of Bruker Corporation, was granted 15,794 restricted stock units (RSUs) and 12,803 derivative awards (stock options) on August 15, 2026. Simultaneously, 2,724 shares were withheld by the company (disposed) to satisfy tax withholding obligations at $57.70 per share, totaling $157,175. The awards were reported on a Form 4 filed August 18, 2026.

Key Details

  • Transaction date(s): August 15, 2026 (reported on Form 4 filed August 18, 2026).
  • Grants: 15,794 RSUs (acquired, $0.00 per share) and 12,803 derivative awards/options (acquired, $0.00).
  • Tax withholding/disposition: 2,724 shares withheld at $57.70 each, total value $157,175 (reported as "disposed" to satisfy taxes).
  • Vesting: RSUs vest in equal installments on the first through fourth anniversaries of Aug 15, 2026 (F1). Stock options vest in equal installments over the same four-year schedule (F3).
  • Tax withholding note: The 2,724 shares represent shares withheld by the company to satisfy tax withholding obligations on vesting (F2).
  • Shares owned after transaction: Not specified in the summary data provided.
  • Filing timing: Form 4 filed Aug 18, 2026 for an Aug 15 transaction — check the official filing for any timeliness designation.

Context

  • The primary activity is issuance of equity compensation (RSUs and options), not an open-market purchase or voluntary sale. Such grants are routine compensation for executives.
  • The withholding of shares is a common means to satisfy tax obligations on vesting and does not necessarily indicate a voluntary sale by the insider.
  • Options are reported as derivative awards; they vest over four years per the footnote and are not described as exercised or sold in this filing.